Navigation Links
Cancer patients may benefit from reporting symptoms online in real time

NEW YORK, November 29, 2007 Traditionally, clinicians have relied on information provided by cancer patients during their office visits as the primary means of assessing patients symptoms and side effects. However, potentially serious consequences could arise if important symptoms go unreported during those visits because they occur between appointments.

A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) finds that even the sickest cancer patients are willing and able to self-report symptoms using the Internet, thus supplying key data in real time to their healthcare providers.

Published in the December 1, 2007, issue of the Journal of Clinical Oncology, the study suggests a new direction in cancer care. According to the authors, supplementing traditional office visit discussions with online patient self-reporting can fill important gaps in clinicians knowledge and in doing so may significantly improve patient safety and quality of care.

Cancer care has become increasingly complex, causing office visits to become more compressed. This makes it challenging for the clinician to comprehensively assess each patients symptoms in that brief window of time, said the studys lead author, Ethan Basch, MD, a medical oncologist at MSKCC. Because cancer therapies can be highly toxic, early detection of symptoms and timely treatment is vital. What is exciting to us about online self-reporting is that patients can alert clinicians to crucial symptoms in real time.

The research team developed a Web-based system that patients in the study could access using computers in waiting-room kiosks and at home to communicate their symptoms directly to clinicians. Investigators adapted the National Cancer Institutes standard terminology for tracking patient toxicities in clinical trials and translated it into patient-friendly language. The new terms were uploaded to a secure Web site called Symptom Tracking and Reporting (STAR). Participants used the system to report their cancer- and chemotherapy-related side effects, including pain, fatigue, constipation, diarrhea, nausea, vomiting, shortness of breath, and decreased mobility, as well as their overall quality of life.

From June 2005 through March 2006, 107 lung cancer patients receiving outpatient chemotherapy at MSKCC enrolled in the study. Patients were followed for up to 16 months and 40 visits. Most enrollees were between the ages of 50 and 69, although 28 percent were older than 70. Patients were more likely to use the system if they had prior computer experience; however, age, gender, and cancer stage had no effect on log-in rates.

Researchers found that 100 percent of patients used the waiting room kiosks at some or all of their office visits. An average of 78 percent of participants logged in to the system at any given office visit.

According to the findings, patients were satisfied with the system. Most respondents (98 percent) found STAR easy to use, 90 percent said it was useful, and 77 percent expressed that it improved the quality of their discussions with clinicians.

Our study suggests that the broader use of patient self-reporting in oncology would be beneficial, said study co-author Mark G. Kris, MD, Chief of the Thoracic Oncology Service at MSKCC. STAR makes it easier for patients to provide information to their doctors about their symptoms and side effects. The fact that this information can be collected anywhere and immediately stored and shared hastens and expands our research efforts as well.

Optional home access to STAR was also offered to study participants. Home users accessed STAR more frequently than clinic-only users, with an average of 23 online sessions versus nine, respectively. Although 76 percent of patients had home computers, only 15 percent reported from home, possibly due to a lack of regular reminders, and to the perception among participants that self-reported information was not being explicitly addressed by clinicians.

Patients were informed that no clinician would regularly monitor STAR reports between visits, and therefore should contact staff directly if severe of disabling symptoms occurred at home. Nonetheless, an automated alert system was integrated so that anytime a patient entered a symptom above a certain level of severity, an on-screen message appeared encouraging the patient to contact a clinician, and an e-mail warning was automatically sent to a designated nurse.

Although the study focused on the patient experience, its results suggest that self-reported data is a potentially valuable resource for clinicians as well. At each follow-up office visit, symptom reports were printed for clinical nurses. It was left to the discretion of patients and clinicians whether and how to incorporate STAR reports into their discussions.

All of the nurses who participated in the study understood the reports and felt this information was highly useful for clinical decisions, documentation, and discussions, said Ann Culkin, RN, a nurse on the Thoracic Oncology Service at MSKCC and a co-author of the study.

The nurses all noted that they had altered management based on patient-reported information and alerts from STAR, including recommending medication and lifestyle changes and arranging for additional physician consultations.

The authors concluded that online self-reporting is a feasible long-term strategy for monitoring toxicities during chemotherapy, even among very ill patients. However, explicit reminders to log in and clinician feedback on self-reported information are important to maintain patients continued interest and participation between visits.

These findings lay the groundwork for future research to assess whether patient self-reporting improves the efficiency and comprehensiveness of toxicity monitoring in clinical trials, and whether this approach can improve the quality of routine cancer care by expediting detection of severe or disabling toxicities, said Dr. Basch. These questions are currently being explored by Dr. Basch and his colleagues in a large randomized study at MSKCC and an NCI-sponsored multicenter trial, with results expected in 2009.


Contact: Esther Napolitano
Memorial Sloan-Kettering Cancer Center

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... StatRad , ... added Chris Hafey and Claude Hooton to its board of directors. The announcement ... America (RSNA) 2015 Annual Meeting and continues to strategically transform its focus from ...
(Date:11/28/2015)... ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. EST, ... With possible savings of up to 20% off orders $80 or more to free gifts ... every few hours. , As a competitive e-commerce website for skin care and cosmetic needs, ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... meeting in Washington D.C. revolved around the fact that proper dental care, both at-home ... stressed the link between periodontal disease (more commonly referred to as gum disease) and ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... affecting the health care in America. As people age, more care is needed, ... costs are rising, and medical professionals are being overworked. The forgotten part of ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ... which demands kidney transplantation is expected to boost the market ... for organ transplantation. --> 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ...
(Date:11/26/2015)... November 26, 2015 ... universitetssjukhus ser potential att använda SyMRI för ... för patienter med multipel skleros (MS) ... med SyntheticMR AB för att kunna använda ... sjukhuset. Med SyMRI kan man generera flera ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Italian ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
Breaking Medicine Technology: